Dr. Dapeng Li 李大鹏
Chief Physician
Gynecologic Oncology, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of gynecologic malignancies, including radical and laparoscopic surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. Focus on fertility-sparing surgery for cervical cancer and advanced radiotherapy techniques.
Dr. Li is Chief Physician and Director of the Fourth Gynecology Ward. Research focuses on clinical and basic studies of comprehensive treatments for gynecologic cancers. Dr. Li has received one Second Prize and two Third Prizes in Shandong Provincial Science and Technology Progress Awards, leads multiple national and provincial research projects, and has published over 50 papers.
Professional roles
- Member, Gynecologic Oncology Branch, China Anti-Cancer Association (Youth Committee)
- Standing Committee Member, Gynecologic Oncology Professional Committee, Shandong Anti-Cancer Association
- Vice Chair, Minimally Invasive Surgery Branch, Shandong Obstetrics and Gynecology Alliance
- Member, Obstetrics and Gynecology Branch, Shandong Medical Association (Youth Committee)
Name order: in Chinese the family name comes first (Li Dapeng). Papers usually list the name as Dapeng Li or Li D.
Selected publications
27 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Womens Health, 2025 (senior author): Leukemoid Reaction and Sudden Hearing Loss in Early Cervical Cancer: A Case Report and Review of the Literature. PubMed 41059500
- Mol Clin Oncol, 2024 (senior author): Prognostic value of obesity in patients with cancer treated with immune checkpoint inhibitors: An updated meta‑analysis and systematic review. PubMed 38125744
- J Inflamm Res, 2023 (senior author): Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy. PubMed 38026255
- Oncol Lett, 2022 (first author): Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer. PubMed 35720507
- Appl Bionics Biomech, 2022 (senior author): Clinical Study of Sentinel Lymph Node Detection to Evaluate Pelvic Lymph Node Metastasis to Determine the Prognosis of Patients with Early Cervical Cancer. PubMed 35369006
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion